{"id":"NCT01071954","sponsor":"Amgen","briefTitle":"A Study Evaluating the Safety and Efficacy of Long-term Dosing of Romiplostim in Thrombocytopenic Pediatric Patients With Immune (Idiopathic) Thrombocytopenia Purpura","officialTitle":"An Open Label Study Evaluating the Safety and Efficacy of Long-term Dosing of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune (Idiopathic) Thrombocytopenia Purpura (ITP)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-12-30","primaryCompletion":"2017-01-12","completion":"2017-01-12","firstPosted":"2010-02-19","resultsPosted":"2019-01-29","lastUpdate":"2020-01-18"},"enrollment":66,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"SUPPORTIVE_CARE"},"conditions":["Thrombocytopenia in Pediatric Subjects With Immune Idiopathic Thrombocytopenic Purpura ITP"],"interventions":[{"type":"BIOLOGICAL","name":"Romiplostim","otherNames":["Nplate"]}],"arms":[{"label":"Romiplostim","type":"EXPERIMENTAL"}],"summary":"This is an extension study designed to assess the safety and durability of platelet count increases with romiplostim treatment of thrombocytopenic patients with immune (Idiopathic) thrombocytopenia purpura. This study is available to pediatric patients who have completed a previous romiplostim ITP study and meet the eligibility criteria of this study.","primaryOutcome":{"measure":"Number of Participants With Adverse Events","timeFrame":"From first dose of study drug until 1 week after last dose. The median (minimum, maximum) duration of treatment was 135.0 weeks (5, 363 weeks).","effectByArm":[{"arm":"Romiplostim","deltaMin":64,"sd":null}],"pValues":[]},"eligibility":{"minAge":"1 Year","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":11},"locations":{"siteCount":31,"countries":["United States","Australia","Canada","Spain"]},"refs":{"pmids":["30846500"],"seeAlso":["http://www.amgentrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":19,"n":65},"commonTop":["Headache","Vomiting","Upper respiratory tract infection","Contusion","Epistaxis"]}}